Early bird registration for CCH 2022 ends July 31. This is your once-a-year opportunity to lobby lawmakers on their homefield—and to make a big difference for our profession—don't miss out!
Earlier this week, OCR released guidance for pharmacies that sets forth their obligations under federal civil rights laws, conflicting with some state laws, and raises concerns for our nation's pharmacies and pharmacists.
FDA has two virtual programs of interest to compounding pharmacists.
APC Member and second-generation pharmacist David Rochefort recently announced his candidacy for New Hampshire State Representative for District 1, a newly created 3-seat district.
We need to raise at least $200,000 in the next three weeks in order to continue our "Save cBHT Campaign." If your business benefits from compounded hormone therapy, NOW is the time to give. We can’t go on without you.
You have many compounding software options to choose from but no time to figure out which ones are best for your practice. Get answers during our July 21 webinar.
The only way you can demonstrate the effectiveness of the compounded formulations you dispense daily is via patient-reported outcome data that can be aggregated and shared with FDA.
APC has been working with a national consulting firm, CMSPI, to assess the viability of creating a group purchasing arrangement for our Pharmacy/Facility Members on credit card processing fees.
Attendee registration is now open for APC’s annual DC fly-in, Compounders on Capitol Hill.
We're pleased to welcome our newest PFM members to the fold, bringing the total to 47 pharmacies and facilities that have joined APC as PFMs since March.
FOLLOW US
